ACAD

ACADIA PHARMACEUTICALS INC

Pharmaceutical Preparations · SIC 2834CIK 1070494Held by 7 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:X LINKEDIN EMAIL

7 managers · Q2 2026 13F

13F bookWeight

Baker Bros. Advisors

Baker Bros. AdvisorsPosition history →

5.4%

—

$1.09B

$19.96B13F book · 2026-06-30

OrbiMed Advisors

OrbiMed AdvisorsPosition history →

0.07%

NEW

$<0.01B

$5.25B13F book · 2026-06-30

Renaissance Technologies

Renaissance TechnologiesPosition history →

0.04%

(25.6%)

$0.03B

$72.62B13F book · 2026-06-30

Alps Advisors

Alps AdvisorsPosition history →

0.02%

+21.0%

$<0.01B

$21.33B13F book · 2026-06-30

Royce & Associates

Royce & AssociatesPosition history →

0.02%

NEW

$<0.01B

$12.42B13F book · 2026-06-30

Adage Capital Management

Adage Capital ManagementPosition history →

0.02%

+5,000.0%

$0.01B

$71.32B13F book · 2026-06-30

Bridgewater Associates

Bridgewater AssociatesPosition history →

0.01%

(64.6%)

$<0.01B

$24.38B13F book · 2026-06-30

Weight = position value ÷ the manager's total 13F long-equity value in the same filing — one definition for every row. “1st obs.” marks a position with no earlier stored 13F to compare against — it is not shown as a purchase.